Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Mechanisms of palmitate-induced lipotoxicity in human osteoblasts.

Endocrinology | 2014

The interest in the relationship between fat and bone has increased steadily during recent years. Fat could have a lipotoxic effect on bone cells through the secretion of fatty acids. Palmitate is the most prevalent fatty acid secreted by adipocytes in vitro. Considering that palmitate has shown a high lipotoxic effect in other tissues, here we characterized the lipotoxic effect of palmitate on human osteoblasts (Obs). Initially we tested for changes in palmitoylation in this model. Subsequently we compared the capacity of Obs to differentiate and form bone nodules in the presence of palmitate. From a mechanistic approach, we assessed changes in nuclear activity of β-catenin and runt-related transcription factor 2 (Runx2)/phosphorylated mothers against decapentaplegic (Smad) complexes using Western blotting and confocal microscopy. Quantitative real-time PCR showed negative changes in gene expression of palmitoyltransferase genes. Furthermore, palmitate negatively affected differentiation and bone nodule formation and mineralization by Obs. Although the expression of β-catenin in palmitate-treated cells was not affected, there was a significant reduction in the transcriptional activities of both β-catenin and Runx2. Confocal microscopy showed that whereas Runx2 and Smad-4 and -5 complex formation was increased in bone morphogenetic protein-2-treated cells, palmitate had a negative effect on protein expression and colocalization of these factors. In summary, in this study we identified potential mechanisms of palmitate-induced lipotoxicity, which include changes in palmitoylation, defective mineralization, and significant alterations in the β-catenin and Runx2/Smad signaling pathways. Our evidence facilitates the understanding of the relationship between fat and bone and could allow the development of new potential therapies for osteoporosis in older persons.

Pubmed ID: 24169557 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Smad5 (YY-6) (antibody)

RRID:AB_1129526

This monoclonal targets Human SMAD5

View all literature mentions

Lamin B1 (S-20) (antibody)

RRID:AB_2136305

This polyclonal targets LMNB1

View all literature mentions

RUNX2 (M-70) (antibody)

RRID:AB_2184247

This polyclonal targets RUNX2 (M-70)

View all literature mentions

Smad4 (C-20) (antibody)

RRID:AB_2255136

This polyclonal targets SMAD4

View all literature mentions

GAPDH (6C5) (antibody)

RRID:AB_627679

This monoclonal targets GAPDH (6C5)

View all literature mentions

beta-catenin (12F7) (antibody)

RRID:AB_781850

This monoclonal targets CTNNB1

View all literature mentions